Chang et al. proposed the liver–ovarian axis with reference to SHBG levels and their relationship to PCOS and NAFLD, suggesting that lower SHBG levels are associated with PCOS while also being associated with NAFLD and insulin resistance in women with PCOS [90]. This evidence concerns the gene SHBG and metabolic dysfunction-associated steatotic liver disease.